MyCell Disease and Diversity: Promo Code and Case Studies
Fujifilm Cellular Dynamics appreciates your interest in MyCell® Disease and Diversity Products. Here is the requested information to get started innovating your research.
Contact email@example.com if you have questions.
Click the links to access research fueled by MyCell Disease and Diversity Products.
- Human iPS cell-derived Cardiomyocytes Carrying MYH7-R403Q Exhibit Aspects of Hypertrophic Cardiomyopathy In Vitro
Cardiomyocytes were differentiated from MYH7-R403Q iPSCs and compared to normal iPSC-derived cardiomyocytes by evaluating beat rate, gene expression, and morphology. The results showed that the MYH7-R403Q cardiomyocytes provide a model system for studying diseases such as hypertrophic cardiomyopathy.
- Characterization of an Isogenic Disease Model of Alzheimer’s Disease from Human iPSC-derived Neurons
To build a cellular model that could help to better understand the mechanisms by which Aβ is produced, Cellular Dynamics used iPSC technology and genetic engineering to produce human neurons that exhibit Alzheimer’s disease (AD)-specific profiles. Our studies with these human iPSC-derived neurons highlighted the “disease-in-a-dish” approach for AD drug development. Cortical neurons were differentiated from APP-A673T and APP-A673V iPSCs and compared to normal iPSC-derived neurons.
- Development and Functional Applications of Human iPSC-derived Spinal Motor Neurons
Human iPSC-derived motor neurons, at purities >50%, from multiple donors were characterized and exhibited electrophysiological functionality. These motor neurons were shown to provide a model system for studying diseases such as ALS and muscular dystrophies.
- First, Large-scale, Patient-derived iPSC Initiative with iPSCs Banked from Over 1700 Donors in 2 Years and Counting
This study described the parallel manufacture of high quality iPSCs across multiple donors, disease states, and tissue types.
Request a Quote for MyCell Disease and Diversity Products